Journal of Metabolic and Bariatric Surgery

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2508-5956   pISSN 2287-2930

Table. 3.

Table. 3.

Changes in parameters related to CVD risk after LRYGB

 VariablesBaselinePOD 1 yearARR/AARRRRP value
BMI (kg/m2) 37.30±6.52 27.86±5.310.000
Total cholesterol (mg/dL)210.20±36.76169.25±32.390.000
HDL (mg/dL) 51.02±12.10 59.93±15.150.000
SBP (mmHg)123.36±10.78119.09±16.570.132
Hypertension32 (58.18)24 (43.64)0.021
T2DM27 (49.09)22 (40.00)0.125
Tobacco use13 (23.64)16 (29.09)0.250
Ideal CVD risk 1.18±0.98
FRS (%) 10.47±7.30 6.33±4.594.13390.000
PCE (%) 5.45±6.25 2.75±2.752.70500.000
KRPM (%) 4.53±2.96 3.49±2.131.03230.000
Heart/Vascular age (years) 63.44±14.89 52.58±14.7910.860.000

Variables = number (%); HDL = high-density lipoprotein cholesterol; SBP = systolic blood pressure; FRS = Framingham CVD risk score; PCE = ACC/AHA pooled cohort equation; KRPM = Korean prediction model for ASCVD; ARR = Absolute risk reduction; AAR = Absolute age reduction; RRR = Relative risk reduction.

J Metab Bariatr Surg 2019;8:1-7 https://doi.org/10.17476/jmbs.2019.8.1.1
© 2019 J Metab Bariatr Surg